"Executive Summary: During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.20%, primarily driven by advancements in diagnostic techniques The global Hepatocellular Carcinoma Drugs Market is experiencing significant momentum driven by rapid advancements, increasing demand, and evolving consumer preferences across multiple industries. Recent market research...